The Analgesic Effect of QLB II After Robotic Prostatectomy. (QLB II: Quadratus Lomborum Block II Type)

Not Applicable

Completed

• Conditions: Postoperative Pain
• Interventions: Other: Levobupivacaine in QLB II

• Registration Number: NCT03941899
• Lead Sponsor: San Salvatore Hospital of L'Aquila

Brief Summary

The analgesic effects of Quadratus Lomborum Block II type after robotic-assisted laparoscopic radical prostatectomy, will be assessed.

Detailed Description

Quadratus Lomborum Block II type will be performed before performing robotic-assisted laparoscopic radical prostatectomy.

The post-operative analgesic effect will be assessed, by using Numeric Rate Scale for pain.

The pain assessment will be evaluated during the first 24 hours from surgery. The opioids requirement and side effects will be also assessed.

Study Timeline

• Study Start: 2019-05-06
• Study First Submitted: 2019-05-06
• Study First Submitted QC: 2019-05-06
• Study First Posted: 2019-05-08
• Primary Completion: 2020-12-06
• Study Completion: 2021-04-30
• Status Verified: 2021-05
• Last Update Submitted: 2021-05-01
• Last Update Posted: 2021-05-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 48

Inclusion Criteria

• American Society of Anesthesiologist status I-III
• Written informed consent

Exclusion Criteria

• Body mass Index > 35 kg/m2
• Allergies to local anesthetics
• primaries or secondaries coagulopathies
• addiction to drugs
• severe kidney and liver diseases
• cognitive impairment

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
QLB II	Levobupivacaine in QLB II	Quadratus Lomborum Blocck II type will be performed before robot-assisted laparoscopic radical prostatectomy

Primary Outcome Measures

Name	Time	Method
Analgesia	The first 24 hours from surgery	Pain assessment by using Numeric Rate Scale for pain

Secondary Outcome Measures

Name	Time	Method
Opioids	The first 24 hours from surgery	The opioids requirement (mg of equianalgesic morphine) will be assessed
Postoperative Nausea and Vomiting	The first 24 hours from surgery	The postoperative nausea and vomiting will be assessed
Length of stay	Day after surgery	The length of stay after surgery will be assessed
Bowel function	The first 24 hours from surgery	The recovery of bowel function will be assessed

Trial Locations

Locations (1)

San Salvatore Academic Hospital; 🇮🇹 Coppito, L'Aquila, Italy